A major problem in cancer management is metastasis - contributed to by the recurrent migration and invasion of tumor cells in the vasculature and tissue parenchyma which parenchyma which perpetuate tumors at multiple locations in the body. Of the many types of cancers facing diagnosis and treatment breast carcinoma has been increasing at an alarming rate in the United States over the past two decades. From a clinical point of view, early detection of breast carcinoma determines diseases prognosis. Unfortunately, there is good evidence to suggest that at the time of diagnosis, a high proportion of patients already have occult or clinically detectable metastasis. Thus, there is a dire need to identify additional prognostic markers for disease progression. This proposal seeks support to study a novel mammary associated gene - called maspin (mammary serine protease inhibitor), which has tremendous diagnostic as well as therapeutic value. However, the biological mechanism(s) of action governing its function(s) remain enigmatic.
Aim 1 : To investigate the molecular mechanisms(s) that mediate maspin inhibition of breast cancer cell motility (including migration an invasion).
This aim will examine the nature of maspin function with respect to the regulation of pericellular proteolysis and interrelatedintegrin/uPAR function - which are critical components of tumor cell invasion of ECMs (extracellular matrices). Hypothesis; Maspin affects breast cancer cell migratory and invasive activity by inhibiting the extracellular proteolysis of EMC components which is regulated by an integrin- mediated event involving uPAR.
Aim 2 : To characterize the intracellular signaling intermediates that are involved in the integrin/uPAR-mediated response to maspin.
This aim will allow us to elucidate our most recent observations regarding the role of the cytoskeleton with respect to change(s) in cell shape and locomotion - coordinated events in cell migration - in response to maspin. Hypothesis: Maspin inhibits cell motility by altering integrin-mediated attachment to specific ECM components - which consequently affects cell shape and locomotion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA075681-04
Application #
6172695
Study Section
Special Emphasis Panel (ZRG2-MEP (01))
Program Officer
Mohla, Suresh
Project Start
1997-07-15
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
4
Fiscal Year
2000
Total Cost
$227,759
Indirect Cost
Name
University of Iowa
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Khalkhali-Ellis, Zhila; Hendrix, Mary J C (2014) Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon. Biol Med (Aligarh) 6:
Bodenstine, Thomas M; Seftor, Richard E B; Seftor, Elisabeth A et al. (2014) Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics. Mol Cancer Res 12:1480-91
Bodenstine, Thomas M; Seftor, Richard E B; Khalkhali-Ellis, Zhila et al. (2012) Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev 31:529-51
Watanabe, Kazuhide; Meyer, Matthew J; Strizzi, Luigi et al. (2010) Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28:1303-14
Margaryan, Naira V; Kirschmann, Dawn A; Lipavsky, Alina et al. (2010) New insights into cathepsin D in mammary tissue development and remodeling. Cancer Biol Ther 10:457-66
Abbott, Daniel E; Margaryan, Naira V; Jeruss, Jacqueline S et al. (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9:23-30
Bailey, Caleb M; Margaryan, Naira V; Abbott, Daniel E et al. (2009) Temporal and spatial expression patterns for the tumor suppressor Maspin and its binding partner interferon regulatory factor 6 during breast development. Dev Growth Differ 51:473-81
Strizzi, Luigi; Postovit, Lynne-Marie; Margaryan, Naira V et al. (2008) Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29:91-103
Bailey, Caleb M; Abbott, Daniel E; Margaryan, Naira V et al. (2008) Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner. Mol Cell Biol 28:2235-43
Bailey, Caleb M; Hendrix, Mary J C (2008) IRF6 in development and disease: a mediator of quiescence and differentiation. Cell Cycle 7:1925-30

Showing the most recent 10 out of 23 publications